0
Quality Score
Niche
CONTOUR DIABETES app (IT)
✍️ bumetric analysis
“
CONTOUR DIABETES app (IT) is an Android app from Ascensia Diabetes Care in the Medical category, currently rated — across few ratings. Initial signal reads as mixed reviews: supporters praise core features while critics cite stability and value gaps.
Quality Score is 0: Niche (micro-niche or pre-traction stage). For a Medical app, that means micro-niche or pre-traction stage. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
💰 Revenue · today and ahead
Today
$500/mo
In 12 months
$437 – $1575
In 24 months
$405 – $3644
INDIE tier
💡 Grow this revenue
Free AI audit of this app’s store listing
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
Typical impact: +2-5× organic installs
📊 Performance Tracking LIVE
Loading…
Rating
—
Reviews
—
Forecast Revenue / mo
—
Snapshots tracked
0
since first record
🍎Also on iOS
$1.2K/mo · 1K ratings · 3.2★
View →
💰 Estimated build cost
$120K
Likely range: $90K – $160K
Synthetic estimate derived from category, file size, screen count, monetization layer, and platform reach. Methodology benchmarks: Clutch + GoodFirms 2024-2026 agency surveys. See /methodology.
Breakdown
| MVP baseline (design + 1-store ship) | +$28K |
| 5 unique screens × $4.5K | +$22K |
| Medical complexity ×1.55 | +$27K |
| Cross-platform reach (iOS + Android) | +$43K |
🔬
How we forecast this revenue
LOW CONFIDENCEBaseline
$500/mo · ML-estimated from 234 triggers
Growth rate
+6.0% MoM · INDIE tier baseline (compound monthly)
Direction
Headwinds: rating drift may slow acquisition
6 months
$426 – $993
12 months
$437 – $1.6K
24 months
$405 – $3.6K
Compound growth at +6.0% MoM (tier baseline for INDIE). Range widens with horizon — typical noise band ±40% at 6mo.. Ranges widen with horizon — distant futures carry more uncertainty.
📊
BU Investment Matrix
Pre-traction · 37/100INDIE TIERlimited signalRevenue Strength
2.7
Product Quality
0.0
Market Position
0.0
Growth Velocity
5.0
Defensibility
5.0
Operational Safety
10.0
Founder Strength
6.2
Monetization Maturity
1.0
- 💰 Revenue: Marginal — $200 - $1250/mo · INDIE tier · medium confidence, trajectory unclear.
- ⭐ Quality: None★ across 0 reviews — weak — significant quality concerns.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: Insufficient signal to assess trajectory.
- ⚠️ Risk: Low — no material risk signals detected.
🎯 For competitors: Mixed picture. Worth competing if you have a clear UX or pricing edge — otherwise crowded segment.
💵 For acquirers: Estimated asking range 18-32× monthly = $9K-$16K. Portfolio play ($5K/mo combined) commands premium.
Composite of 8 dimensions computed deterministically from public signals — no LLM, every score traces back to a measurable input. Default weights shown; "compete" / "acquire" / "invest" lenses re-weight without re-fetching.
🔔
Track this app’s revenue
FREEGet an email when revenue moves by your threshold. No spam, unsubscribe in one click.
Range:
💰 Forecast Revenue / mo
MODELRevenue forecast computed from BU's 234 trigger model on each snapshot. Calibrated against ground-truth from 58 verified-revenue apps.
📈 Reviews Growth
LIVECumulative review count from first BU snapshot. Each point = a tracked update.
⭐ Rating Trend
LIVEAverage rating evolution. Updates with each new review batch.
App Specs
🔐 Own this app? Claim & verify MRR →🔖 vVaries with device📂 Medical💰 Free
📝 About this app
The easy-to-use CONTOUR™DIABETES app is designed for adults of all ages with diabetes.(1) Since 2016, there have been over 1.2 million downloads.(2) Start your download and enjoy your journey.
People using the system say they:(1,3)
• better understood their diabetes
• significantly decreased HbA1c values
• didn't find it to be a hassle that compromised their quality of life
The CONTOUR™DIABETES app syncs with a CONTOUR™ connected meter for seamless blood glucose monitoring.… View full description on the official store →
People using the system say they:(1,3)
• better understood their diabetes
• significantly decreased HbA1c values
• didn't find it to be a hassle that compromised their quality of life
The CONTOUR™DIABETES app syncs with a CONTOUR™ connected meter for seamless blood glucose monitoring.… View full description on the official store →
Profile & Insights
Everything we know — and don't — about this app and its company.
Identification
- App name
- CONTOUR DIABETES app (IT)
- Developer
- Ascensia Diabetes Care
- Bundle ID
- com.ascensia.contour.it
- App Store URL
- Open in App Store
- Category
- Medical
- Content rating
- Not found
- Languages
- Not found
Company
- Website
- diabetes.ascensia.com
- Tagline
- Not found
- Description
- Not found
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Not found
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $362/mo
- Top-grossing rank
- Not found
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Founder data not yet collected for this app.
Funding
Funding data not yet collected for this app.
Press & Links
Press & Links data not yet collected for this app.
Contacts & Socials
Contacts & Socials data not yet collected for this app.
Profile is built from iTunes Lookup + developer site scrape + ML revenue model. Empty fields show "Not found" — additional sources (Crunchbase, X, IndieHackers, Acquire.com) coming.
More by Ascensia Diabetes Care
View all →📦 Portfolio summaryINDIE studio
17apps·$5K/mocombined
✓ Diversified — top app contributes 11%; risk spread across portfolio
Full revenue analysis
Read the article-style breakdown for CONTOUR DIABETES app (IT): category rank, percentile, growth signal, comparable apps, and how the forecast is calibrated against verified-MRR anchors in this niche.